A series of molecular
salts of the antimalarial drug pyrimethamine
(PYR) with salicylic acid (SA) and its methyl-substituted
derivatives 3-methylsalicylic acid (3Me-SA), 4-methylsalicylic
acid (4Me-SA), and 5-methylsalicylic acid (5Me-SA) was obtained. Additionally, cocrystallization of PYR with the structural analogues of SA 3-hydroxybenzoic
acid (3OH-BA) and 4-hydroxybenzoic acid (4OH-BA) led in the case of 3OH-BA to the formation of a molecular
salt, while cocrystallization with 4OH-BA did not lead
to the formation of an associate of any kind. In all obtained crystal
structures, the carboxylate anion interacts with the protonated at
N1 pyrimethamine moiety in a linear fashion through a pair of parallel
N–H···O hydrogen bonds forming a cyclic hydrogen-bonded
motif. In the crystal structure of PYR-SA as well as
in the structures involving methylated derivatives of SA (3Me-SA, 4Me-SA, and 5-Me-SA), a typical PYR-PYR association via a
pair of N–H···N bonds between the N(4)H2 amino group of one molecule and the N3 unsubstituted amino
atom of the second PYR molecule is observed, a motif
that is characteristic of two known PYR polymorphs. On
the other hand, in the structure of PYR-3OH-BA, the PYR-PYR connection is realized via
a pair of N–H···N bonds between the N(2)H2 amino group of one molecule and the N3 unsubstituted amino
atom of the second PYR molecule. In all of the structures,
chlorine atoms are involved in C–H···Cl interactions
with either the acid molecule or another PYR moiety,
while in the structure of PYR-3Me-SA molecules are additionally
connected through halogen Cl···Cl interactions. All
of the obtained structures were thoroughly characterized by single-crystal
X-ray analyses, Hirshfeld analyses, DFT calculations, and thermal
analyses (TGA and DSC).